디클록사실린 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "디클록사실린" in Korean language version.

refsWebsite

Global rank Korean rank

4^th place

4^th place

2^nd place

3^rd place

1books.google.com

3^rd place

9^th place

1web.archive.org

1^st place

1^st place

447^th place

433^rd place

books.google.com

Fischer J, Ganellin CR (2006). 《Analogue-based Drug Discovery》. John Wiley & Sons. 491쪽. ISBN 9783527607495.

doi.org

dx.doi.org

Miranda-Novales G, Leaños-Miranda BE, Vilchis-Pérez M, Solórzano-Santos F (October 2006). “In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains”. 《Annals of Clinical Microbiology and Antimicrobials》 5: 25. doi:10.1186/1476-0711-5-25. PMC 1617116. PMID 17034644.

fda.gov

“Competitive Generic Therapy Approvals”. 《U.S. Food and Drug Administration (FDA)》. 2023년 6월 29일. 2023년 6월 29일에 원본 문서에서 보존된 문서. 2023년 6월 29일에 확인함.

nih.gov

ncbi.nlm.nih.gov

Miranda-Novales G, Leaños-Miranda BE, Vilchis-Pérez M, Solórzano-Santos F (October 2006). “In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains”. 《Annals of Clinical Microbiology and Antimicrobials》 5: 25. doi:10.1186/1476-0711-5-25. PMC 1617116. PMID 17034644.

web.archive.org

“Competitive Generic Therapy Approvals”. 《U.S. Food and Drug Administration (FDA)》. 2023년 6월 29일. 2023년 6월 29일에 원본 문서에서 보존된 문서. 2023년 6월 29일에 확인함.